Fat-soluble vitamin deficiency and toxicity: Pathology review

Last updated: November 01, 2022

Fat-soluble vitamin deficiency and toxicity: Pathology review

Medicine 2CK

Medicine 2CK

Immunodeficiencies: Clinical
Antihistamines for allergies
Glucocorticoids
Advanced cardiac life support (ACLS): Clinical
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Coronary artery disease: Clinical
Heart failure: Clinical
Syncope: Clinical
Pericardial disease: Clinical
Cardiomyopathies: Clinical
Hypertension: Clinical
Hypercholesterolemia: Clinical
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Diabetes mellitus: Clinical
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Hypopituitarism: Clinical
Cushing syndrome: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
MEN syndromes: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Esophageal disorders: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Gastroparesis: Clinical
Malabsorption: Clinical
Inflammatory bowel disease: Clinical
Jaundice: Clinical
Cirrhosis: Clinical
Laxatives and cathartics
Antidiarrheals
Acid reducing medications
Fever of unknown origin: Clinical
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Anemia: Clinical
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Leukemia: Clinical
Lymphoma: Clinical
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Thrombophilia: Clinical
Myeloproliferative neoplasms: Clinical
Plasma cell disorders: Clinical
Blood products and transfusion: Clinical
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Infective endocarditis: Clinical
Pneumonia: Clinical
Tuberculosis: Pathology review
Diarrhea: Clinical
Viral hepatitis: Clinical
Urinary tract infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Bites and stings: Clinical
HIV and AIDS: Pathology review
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Metabolic and respiratory acidosis: Clinical
Metabolic and respiratory alkalosis: Clinical
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Environmental and chemical toxicities: Pathology review
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
Stroke: Clinical
Seizures: Clinical
Headaches: Clinical
Dementia and delirium: Clinical
Hyperkinetic movement disorders: Clinical
Hypokinetic movement disorders: Clinical
Muscle weakness: Clinical
Disorders of consciousness: Clinical
Spinal cord disorders: Pathology review
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Migraine medications
Anti-parkinson medications
Medications for neurodegenerative diseases
Asthma: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Diffuse parenchymal lung disease: Clinical
Venous thromboembolism: Clinical
Acute respiratory distress syndrome: Clinical
Pleural effusion: Clinical
Pneumothorax: Clinical
Lung cancer: Clinical
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Joint pain: Clinical
Rheumatoid arthritis: Clinical
Seronegative arthritis: Clinical
Systemic lupus erythematosus (SLE): Clinical
Sjogren syndrome: Clinical
Inflammatory myopathies: Clinical
Vasculitis: Clinical
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
Eczematous rashes: Clinical
Papulosquamous skin disorders: Clinical
Alopecia: Clinical
Hypersensitivity skin reactions: Clinical
Autoimmune bullous skin disorders: Clinical
Blistering skin disorders: Clinical
Hypopigmentation skin disorders: Clinical
Benign hyperpigmented skin lesions: Clinical
Skin cancer: Clinical

Transcript

Watch video only

At the clinic, 32 year old Naya comes in with bilateral hip pain. She exercises regularly and has not changed anything in her routine recently. She mentions that she has recently also started to experience blurry vision, and has scheduled an appointment with her ophthalmologist. In addition, she mentions that her skin is unusually dry, which hasn’t improved with moisturizing cream. She takes several tablets of cod liver oil supplements daily. Physical examination reveals an enlarged liver and spleen. Next to her, 2 year old Lorenzo has been brought to the clinic by his mother for a yearly pediatric checkup. He was diagnosed with chronic kidney disease about one year ago in Italy. They then migrated to the United Kingdom. On examination, there is lateral bowing of the legs, as well as beading of the ribs along the anterior side of the chest.

Based on the initial presentation, both Naya and Lorenzo seem to have some form of fat- soluble vitamin deficiency or toxicity. Fat- soluble vitamins include vitamins A, D, E, and K. Just like all vitamins, they need to be attained by diet. So, inadequate dietary consumption can be the cause of their deficiency. In a test question, some big clues are that the affected individuals often come from lower income countries or have an eating disorder like anorexia nervosa. Now, in the small intestine, fat- soluble vitamins are absorbed along with dietary fats, which means that anything affecting fat absorption can also affect the absorption of fat-soluble vitamins. Fat malabsorption typically presents with steatorrhea, meaning fatty, greasy, floating, voluminous, and terribly smelling stools. But a deficiency of fat-soluble vitamins might be the only clue you get for that. Now, causes of fat malabsorption can be broadly divided into two major groups: digestive disorders where the food can’t be broken down in the intestinal lumen, and absorption defects where the intestinal mucosa can’t take in the nutrients.

For your exams, the most common digestive disorders are exocrine pancreatic insufficiency and cholestasis. In exocrine pancreatic insufficiency, there’s a lack of pancreatic digestive enzymes, including lipase, which breaks down lipids. Now, what’s important to remember is that exocrine pancreatic insufficiency typically results from chronic pancreatitis, which is inflammation of the pancreas leading to the destruction of its exocrine portion. In adults, the greatest risk factor for chronic pancreatitis is alcohol abuse, whereas if you see chronic pancreatitis in a child, remember that the number one cause is cystic fibrosis. Fat digestion could also be affected by cholestasis, where not enough bile is reaching the intestine to emulsify fats and make them easier to absorb. Cholestasis can be hepatocellular, where hepatocytes don’t make enough bile, and commonly tested causes include increased estrogen like in pregnancy or oral contraceptive use. It could also be due to obstruction where something’s physically blocking bile flow. In a test question, think of obstructive cholestasis if you see a tumor in the head of the pancreas, primary sclerosing cholangitis, in an individual with a history of inflammatory bowel disease, or biliary atresia in a newborn.

Fat malabsorption can also be caused by absorption defects. Here we have diseases that cause damage to the small intestine mucosa, reducing the surface area available for absorption. These include celiac disease, which is an autoimmune condition where the gluten in food triggers the body’s immune cells to attack the intestinal mucosa. There’s also tropical sprue, which is thought to be the result of bacterial overgrowth in the intestines, and mostly affects tropical regions of the world, like the Caribbean, India, and Southeast Asia. Finally, there’s Whipple’s disease, which is caused by Tropheryma whipplei. Remember that Whipple’s disease also affects large joints, causing migratory arthralgias.

Okay, now, another high- yield fact for fat- soluble vitamins is that they can be stored in fat cells instead of getting excreted in the urine. And that is why their toxicity, also known as hypervitaminosis, is way more common than that of water- soluble vitamins. The number one cause of hypervitaminosis is excess intake of vitamin supplements, highly fortified foods, or medications containing a derivative of the vitamin.

Okay, now let’s dive into the various fat- soluble vitamins. Let’s start with vitamin A, also known as retinol, which is found mostly in fruits, leafy vegetables, as well as animal liver products, egg yolk, and dairy products. Normally, vitamin A is essential for the production of rhodopsin, which is an eye pigment found in the retina that allows us to see in dark or dim lighting. Other important functions of vitamin A include helping epithelial cells differentiate, and functioning as an antioxidant that helps boost the immune system.

Now, for clues of vitamin A deficiency, look for someone with inadequate consumption of fruits or vegetables or a condition causing fat malabsorption. The most classic symptom is night blindness, also known as nyctalopia, due to the decreased production of rhodopsin. Other high- yield eye manifestations include keratomalacia, which is the degeneration of the cornea, and Bitot spots, which are triangular, oval, or irregular foamy spots on the conjunctiva, resulting from squamous metaplasia and buildup of keratin debris in the cornea. Deficiency of vitamin A can also affect the skin, causing dryness, itchiness, and peeling with white flakes, also known as xerosis cutis, as well as the immune system, causing an increased susceptibility to infections.

Now, for vitamin A toxicity, think of an individual with excess intake of vitamin A. This is usually in the form of supplements. But for your exams, what’s high yield is that vitamin A is also given in severe cases of measles. A vitamin A derivative, called isotretinoin, is also administered orally to treat severe acne, while another metabolite, called all-trans retinoic acid, or ATRA for short, is used in acute promyelocytic leukemia or APL. Now, symptoms vary depending on whether the toxicity is acute, meaning that it occurs over a few hours or days, or chronic, in which case it lasts for months or years. Acute toxicity typically presents with blurry vision, nausea, vomiting, and vertigo. In contrast, chronic toxicity can present with hair loss, dry or peeling skin, hepatosplenomegaly or liver and spleen enlargement, and arthralgias or joint pain. For your exams, a highly tested fact is that chronic toxicity can also cause elevated intracranial pressure. Some clues to this might be a persistent headache, cerebral edema, and papilledema, or swelling of the optic disk.

Another high- yield fact examiners want you to know is that excess vitamin A, during the first trimester of pregnancy, can be teratogenic and affect the baby. So before prescribing medications that contain a derivative of the vitamin, such as isotretinoin, make sure that there are two negative pregnancy tests and that the individual applies two contraception methods.

Alright, next up is vitamin D. Now, active vitamin D starts out as one of two metabolically inactive molecules. Either vitamin D2, which comes from plants, fungi and yeast, and vitamin D3 which can either come from fish, milk, or plants in our diet, but can also be made by our own skin cells when they are exposed to UV rays from the sunlight. Both vitamin D2 and D3 first get to the liver, where the enzyme 25-hydroxylase turns them into 25-hydroxy-vitamin D. This can then travel to the proximal tubules of the kidneys and meet the enzyme 1-alpha-hydroxylase, which turns them into 1,25-hydroxy-vitamin D. And that’s the active form of vitamin D. Now, what’s especially important to note is that activation of vitamin D can be triggered by parathyroid hormone when calcium or phosphate levels are low. More specifically, parathyroid hormone, low calcium, and low phosphate cause the renal cells in the proximal tubule to increase their synthesis of 1-alpha-hydroxylase. The effects of activated vitamin D include stimulating bone resorption at high levels and bone mineralization at low levels. Vitamin D also promotes calcium and phosphate absorption in the small intestine, as well as calcium and phosphate reabsorption in the kidneys. So, remember that active vitamin D ultimately leads to an increase in blood levels of both calcium and phosphate. Make sure you don’t confuse that with parathyroid hormone, which stimulates calcium reabsorption, while inhibiting phosphate reabsorption in the kidney, resulting in an increase in calcium, but a decrease in phosphate levels.

Causes of vitamin D deficiency once again include inadequate dietary intake and fat malabsorption. Regarding inadequate intake, newborn infants, especially premature ones who are exclusively breastfed are at high risk for vitamin D deficiency, and that’s a high yield fact! That’s because breast milk typically doesn’t contain adequate amounts of vitamin D. For that reason, it’s important that breastfed infants receive oral vitamin D drops. Okay, but what’s unique about vitamin D deficiency is that it can be also caused by inadequate exposure to UV light. In a test question, look for individuals who have recently immigrated from a sunny area to an area without a lot of sun. Also, keep in mind that for unknown reasons, individuals with darker skin tone seem to be at higher risk. Another cause of vitamin D deficiency is chronic liver disease, due to the liver's inability to turn vitamin D2 and D3 into 25-hydroxy-vitamin D. The same goes for chronic kidney disease, where the kidneys can’t turn 25-hydroxy-vitamin D into 1,25-hydroxy-vitamin D. In addition, vitamin D deficiency has been linked to the use of medications like phenytoin, an anticonvulsant that’s metabolized by the same liver and kidney hydroxylase enzymes that are needed for the synthesis of vitamin D.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Sarcoidosis and calcium homeostasis disturbances—Do we know where we stand?" Chronic Respiratory Disease (2019)
  5. "Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline" (1998)